Results 131 to 140 of about 1,786 (140)

Assessing symptomatic vulvar, vaginal, and lower urinary tract atrophy

Climacteric, 2019
Santiago Palacios
exaly  

Incidence of genitourinary conditions in women with a diagnosis of vulvar/vaginal atrophy

Current Medical Research and Opinion, 2014
Rossella E Nappi, Liisa Palmer
exaly  

Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions

Climacteric, 2017
Placido Llaneza Coto, Santiago Palacios
exaly  

Vulvar and Vaginal Atrophy in Postmenopausal Women: Findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) Survey

Journal of Sexual Medicine, 2013
Sheryl A Kingsberg, Michael L Krychman
exaly  

Ospemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical use

Expert Opinion on Pharmacotherapy, 2015
JoAnn Pinkerton, Risa Kagan
exaly  

Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial

Climacteric, 2015
R C Rosen, S A Kingsberg, G Constantine
exaly  

TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women

Climacteric, 2019
J A Simon, D F Archer
exaly  

The American–European difference in vulvar and vaginal atrophy views: a lesson from the REVIVE Survey

Climacteric, 2016
Rossella E Nappi
exaly  

Perceptions of Dyspareunia in Postmenopausal Women with Vulvar and Vaginal Atrophy: Findings from the Revive Survey

Women's Health, 2014
exaly  

Helping Women Understand Treatment Options for Vulvar and Vaginal Atrophy.

Nursing for Women's Health, 2015
exaly